ST
STWI
StageWise Strategies Corp.
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Jun 11, 2026
SEC
StageWise Strategies Corp. filed an 8-K reporting a change in control. Artikkhodjaev Jakhongir Abidovich entered into tw
8-K — Impact 5/10
May 20, 2026
SEC
StageWise Strategies Corp. filed an amended 10-Q (10-Q/A) to correct three non-financial errors: (1) authorized shares c
10-Q/A — Impact 6/10
May 20, 2026
SEC
StageWise Strategies Corp. filed Amendment No. 1 to its 10-K for FY2025 to correct and expand related-party transaction
10-K/A — Impact 6/10
Latest Reports
NEUTRAL
8-K
5/10
StageWise Strategies Corp. filed an 8-K reporting a change in control. Artikkhodjaev Jakhongir Abidovich entered into tw
Jun 11, 2026
BEARISH
10-Q/A
6/10
StageWise Strategies Corp. filed an amended 10-Q (10-Q/A) to correct three non-financial errors: (1) authorized shares c
May 20, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 5.7/10.
NEUTRAL
8-K
5/10
StageWise Strategies Corp. filed an 8-K reporting a change in control. Artikkhodjaev Jakhongir Abido
Jun 11, 2026
BEARISH
10-Q/A
6/10
StageWise Strategies Corp. filed an amended 10-Q (10-Q/A) to correct three non-financial errors: (1)
May 20, 2026
BEARISH
10-K/A
6/10
StageWise Strategies Corp. filed Amendment No. 1 to its 10-K for FY2025 to correct and expand relate
May 20, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.